(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin
Modify Date: 2025-09-21 09:12:08
![(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin Structure](https://www.chemsrc.com/extcaspic/418/162869-75-2.png)
(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin structure
|
Common Name | (3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin | ||
|---|---|---|---|---|
| CAS Number | 162869-75-2 | Molecular Weight | 298.37 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H26O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | (3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin |
|---|
| Molecular Formula | C16H26O5 |
|---|---|
| Molecular Weight | 298.37 |
| InChIKey | SXYIRMFQILZOAM-CVRZQRFUSA-N |
| SMILES | COC1OC2OC3(C)CCC4C(C)CCC(C1C)C24OO3 |
|
Name: insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen
Source: 846
Target: N/A
External Id: 5mMGluc_INS1E_InsulinRelease_40mMGluc_SP
|
|
Name: HT-29 viability from Cell TiterGlo-IC50
Source: 846
Target: N/A
External Id: Basal_Viability_ATP_HT-29_CRC
|
|
Name: HCT116 viability from Cell TiterGlo-IC50
Source: 846
Target: N/A
External Id: Basal_Viability_ATP_HCT116_CRC
|
|
Name: Colo320 viability from Cell TiterGlo-IC50
Source: 846
Target: N/A
External Id: Basal_Viability_ATP_Colo_320_CRC
|
|
Name: VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50
Source: 846
Target: N/A
External Id: VEGF_ADSC_ECFC_Angio_CD31_TubeArea_CRC
|
|
Name: GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen
Source: 846
Target: N/A
External Id: GSK3b_inh_pretreated_Viability_ATP_HCT116_SP
|
|
Name: GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50
Source: 846
Target: N/A
External Id: GSK3b_inh_pretreated_Viability_ATP_HCT116_CRC
|
|
Name: SW480 viability from Cell TiterGlo-IC50
Source: 846
Target: N/A
External Id: Basal_Viability_ATP_SW480_CRC
|
|
Name: Cytotoxicity counterscreen for inhibitors of SARS-CoV-2 cell entry
Source: NCGC
Target: N/A
External Id: TRND-SARS-CoV-2-cytotox-48hr
|
|
Name: GLP1 secretion from NCI-H716 cells-screen
Source: 846
Target: N/A
External Id: hNCI-H716_GLP1_Secretion_SP
|
Total 25, Current Page 1 of 3
1
2
3